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Two-dimensional gel electrophoresis of proteins labeled with 32PI in S49 mouse lymphoma cells revealed 
five phosphoproteins that were rapidly and reversibly dephosphorylated in response to elevation of cyclic 
AMP (CAMP). Under basal conditions, labeling of at least two of these proteins was limited by slow turn- 
over of protein-bound phosphate. The rapid CAMP-mediated dephosphorylation of these species was attri- 
butable, therefore, to stimulation of a specific phosphoprotein phosphatase. 
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1, INTRODUCTION 
In animal systems the primary function of 
CAMP is activation of CAMP-dependent protein 
kinases and concomitant stimulation of specific 
protein phosphorylations [l-3]. Cellular protein 
phosphorylation can also be regulated indirectly by 
CAMP. Several CAMP-independent protein kinases 
are substrates for the CAMP-dependent enzyme, 
and their activities are either stimulated or de- 
pressed by CAMP-dependent phosphorylation 
[4-61. Furthermore, a specific inhibitor of protein 
phosphatase can be activated by CAMP-dependent 
phosphorylation [7,8]. In previous reports from 
this laboratory, high resolution two-dimensional 
gel electrophoresis was used to study CAMP- 
stimulated protein phosphorylations in intact S49 
mouse lymphoma cells [9,10]. Mutants lacking 
catalytic activity of CAMP-dependent protein 
kinase [l 1] were deficient in these responses [9]. 
We show here that elevated CAMP also results in 
Abbreviations: CAMP, cyclic AMP; DME, Dulbecco’s 
modified Eagle’s medium 
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kinase-dependent dephosphorylation of several 
proteins in S49 cells. For at least two phosphopro- 
teins, CAMP enhances rates of dephosphorylation. 
Therefore, it appears that elevation of CAMP can 
cause stimulation of a specific phosphoprotein 
phosphatase. 
2. MATERIALS AND METHODS 
2.1. Materials 
D,L-Isoproterenol, D,L-propranolol, and 3-iso- 
butyl-l-methyl xanthine were from Sigma (St. 
Louis, MO), and [32P]orthophosphoric acid 
(carrier-free in water) was from ICN (Irvine, CA). 
X-ray film (type XAR) and photographic chemi- 
cals were from Eastman Kodak (Rochester, NY), 
and intensifying screens (‘Lightning-plus’) were 
from DuPont (Wilmington, DE). Chemicals for 
two-dimensional gel electrophoresis were obtained 
as in [12]. 
2.2. Methods 
S49 mouse lymphoma cells were grown in 
suspension culture in DME supplemented with 
10% heat-inactivated horse serum as in [12]. Cells 
were labeled with 32Pi n DME prepared with either 
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1 mM orthophosphate (figs 1,2) or no phosphate 
(fig.3) and supplemented with 10% heat-inactivated 
horse serum that had been dialyzed extensively 
against 0.15 M sodium chloride [13]. 
Cells were harvested by centrifugation, washed, 
and resuspended at 2 x lo6 cells/ml in labeling 
media as in [9,13]. For the experiments of figs 1 
and 2, 32Pi was added to 0.5 mCi/ml and cultures 
were labeled for 3.5 (fig.1) or 3 h (fig.2). For the 
experiment of fig.3 cells were preincubated for 30 
min at 37°C before adding 32Pi to 4.4 mCi/ml and 
labeling for 4 min. Drug treatments are described 
in the figure legends. After labeling, cells were 
diluted 5-fold with ice-cold phosphate-buffered 
saline, harvested by centrifuging 5 s at 10000 x g 
and lysed with gel sample buffer containing ap- 
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prox. 9.9 M urea as in [9,13]. Samples of extracts 
containing equal amounts of acid-precipitable 
radioactivity were subjected to two-dimensional 
gel electrophoresis, and labeled proteins were 
detected by direct autoradiography of dried gels 
[9,13]. For the experiment of fig.3, intensifying 
screens were used for enhancement. All gel pat- 
terns are shown with acidic ends of isoelectric 
focusing gel dimensions to the right. 
3. RESULTS AND DISCUSSION 
Fig.1 shows that CAMP has both positive and 
negative effects on protein phosphorylation in in- 
tact S49 mouse lymphoma cells. Isoproterenol, a 
,B-adrenoreceptor agonist, and propranolol, a p- 
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Fig. 1. Isoproterenol stimulates both phosphorylation and dephosphorylation of S49 cell proteins. S49 cells were labeled 
for 3.5 h with 32Pi and either left untreated (a), treated with isoproterenol (final concentration, 5 PM) for the final 15 
min of labeling (b), treated with isoproterenol for the final 30 min of labeling (c), or treated with isoproterenol for the 
final 30 min of labeling and with propranolol (final concentration, 20pM) for the final 15 min of labeling (d). After 
labeling, cells were harvested and lysed, and portions of extracts containing 1.1 x lo6 cpm of acid-precipitable radioac- 
tivity were subjected to two-dimensional gel electrophoresis. Patterns shown are from 6-day autoradiographic exposures 
and contain proteins with PI’S between about 6.2 and 7.0. Filled arrowheads indicate positions of CAMP-inhibited 
phosphoproteins; open arrowheads indicate positions of CAMP-stimulated phosphoproteins. Letter and number 
designations are used in the text o refer to the species indicated. Approximate molecular masses of these species are 
80 kDa for dr, 73 kDa for dz, 46 kDa for d3 and &, 41.5 kDa for ds, 71 kDa for T, and 44 kDa for M. 
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adrenoreceptor antagonist, were used to effect 
rapid increases or decreases of CAMP levels in cells 
prelabeled with 32Pi; high resolution two-dimen- 
sional gel electrophoresis was used to separate 
labeled phosphoprotein species. Cells were in- 
cubated with “Pi for 3 h before adding drugs so 
that intracellular ATP pools would be equilibrated 
with isotope. When cells were treated with isopro- 
terenol for 15 or 30 min (fig.lb,c), labeling of 
some species was stimulated (M and T in portions 
of gel patterns shown), and labeling of several 
other species was depressed (dr-ds). For phospho- 
proteins dr and dz depression of labeling was vir- 
tually complete, but for proteins d3-ds decreases 
were to about 30-50% of basal labeling. As shown 
for stimulatory effects [9], the inhibitory effects of 
isoproterenol on protein phosphorylation ap- 
peared to result from activation of CAMP-depend- 
ent protein kinase: they could be elicited in wild- 
type cells by analogs or inducers of CAMP, but 
they could not be elicited in mutant cells lacking 
catalytic subunit of CAMP-dependent kinase (not 
shown). After incubating cells with isoproterenol 
for 15 min, treatment with propranolol for another 
15 min reversed the effects of isoproterenol on pro- 
teins M and dr-ds (fig. Id). (Dephosphorylation of 
protein T was incomplete after 15 min of treatment 
with propranolol). Since the isoproterenol-mediat- 
ed depression of phosphoprotein labeling could be 
reversed with propranolol, it reflected dephos- 
phorylation rather than degradation of proteins 
dr-ds. 
Fig.2 shows a time course for isoproterenol- 
stimulated dephosphorylations. A cell culture was 
labeled for 3 h with “Pi, and portions were treated 
with isoproterenol (and isobutyl methylxanthine, 
an inhibitor of phosphodiesterases) for times in- 
dicated in the figure legend. Phosphorylation of 
proteins dr, d3, and 4 was decreased maximally 
within 2.5 min of isoproterenol addition, while 
dephosphorylation of protein dz (and ds, not 
shown) was apparently slower. In similar ex- 
periments, samples were taken after adding pro- 
pranolol to 32Pi-labeled cultures that had been 
treated with isoproterenol; rephosphorylation of 
proteins dr, d3, and & was complete within 2 min 
(not shown). 
Net dephosphorylation of proteins could result 
from either inhibition of a protein kinase or 
stimulation of a phosphoprotein phosphatase. 
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Fig.2. Time courses for isoproterenol-stimulated dephos- 
phorylations of proteins dr-Q. Cells were labeled with 
32Pi, extracts were prepared, and gels were run as 
described in section 2. Cultures were either untreated 
(a,b) or treated with 10 ,uM isoproterenol and 50 pM 
3-isobutyl-1-methylxanthine for the final 2.5 min (c,d), 
8 min (e,f), or 20 min (g,h) of labeling; 8.7 x lo5 cpm of 
acid-precipitable radioactivity were loaded onto gels, 
and autoradiograms were exposed for 8 days. Portions 
of gel patterns are shown containing proteins dr and dz 
(a,c,e,g) or proteins d3 and c4 (b,d,f,h). 
Comparison of half-times for dephosphorylation 
under conditions of basal and elevated intracel- 
lular CAMP might distinguish between these two 
mechanisms. The experiment of fig.2 shows that 
half-times for dephosphorylation of proteins dr , 
d3, and & were much less than 2 min under condi- 
tions of elevated intracellular CAMP. The slow 
equilibration of phosphate and ATP pools pre- 
cluded measurement of basal rates of dephosphor- 
ylation by label-chase procedures using 32Pi, but 
the rapid relabeling of phosphoproteins dr, d3, and 
& following addition of propranolol to isopro- 
terenol-treated cells suggested that basal dephos- 
phorylation rates could be estimated from pulse 
labeling experiments. Since proteins whose label- 
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ing was inhibited by isoproterenol should be phos- 
phorylated in basal cells, their labeling with 32Pi 
would require exchange of protein-bound phos- 
phate, Therefore, the extent to which 32Pi could be 
incorporated into these proteins during a short 
pulse would be determined by rates of their de- 
phosphorylation. 
Fig.3 shows results from an experiment in which 
cells were labeled for only 4 min with “Pi. Because 
of nonlinear incorporation, most labeling under 
this procedure occurred during the final 2 min of 
incubation (unpublished). One sample was un- 
treated (fig.3a); a second sample was pretreated 
with isoproterenol and labeled in the presence of 
this agonist (fig.3b); and a third sample was 
pretreated with isoproterenol and then treated with 
propranolol during the labeling period (fig.3c). 
Labeling of proteins dI and d3 was barely detec- 
table in gel patterns from basal or isoproterenol- 
treated cells (fig.3a,b), but it was relatively strong 
in patterns from cells that were treated sequentially 
with isoproterenol and propranolol (fig.3c); phos- 
phoproteins dz, dq, and ds were not detected in any 
of these patterns. Since pretreatment with isopro- 
terenol causes extensive dephosphorylation of pro- 
teins dr and d3 (fig.2), their labeling in fig.3c 
reflects an amount attributable to rephosphoryla- 
tion. Labeling of proteins dr and ds under basal 
conditions requires phosphate turnover; the rela- 
tively poor labeling of these species in fig.3a thus 
reflects slow rates of dephosphorylation (i.e., half- 
times greater than 2 min). We conclude that 
elevated levels of intracellular CAMP stimulate 
dephosphorylation rates for phosphoproteins dr 
and d3, and therefore, that elevated CAMP can 
stimulate activity of a specific phosphoprotein 
phosphatase. 
The isoproterenol-stimulated phosphoprotein M 
provided a positive control for the results discussed 
above. Labeling of this species was strong in 
isoproterenol-treated cells (fig.3b) but relatively 
weak in basal or propranolol-treated cells (fig.3a, 
c). Since pretreatment with isoproterenol was suf- 
ficient to stimulate essentially complete phospho- 
rylation of protein M (unpublished), its labeling in 
the presence of isoproterenol depended on phos- 
phate exchange. (Complete isoproterenol-depend- 
ent phosphorylation of protein T required more 
than 15 min of exposure to the drug, unpublished, 
so labeling of this protein in fig.3b resulted, in 
210 
Fig.3. 32Pi-labeling of CAMP-regulated phosphoproteins 
in a short pulse. Cells were washed, resuspended in 
phosphate-free medium, and preincubated for 30 min at 
37°C before labeling with 32Pi for 4 min. Cells for (a) 
were left untreated, and those for (b) and (c) were 
treated with 5 pM isoproterenol for 5 min before adding 
label. For (c), 20 pM propranolol was added simultane- 
ously with label. Extracts were prepared, and samples 
containing lo5 cpm of acid-precipitable radioactivity 
were subjected to two-dimensional gel electrophoresis. 
Autoradiography (with intensifying screens) was for 14 
days at -70°C. 
part, from de novo phosphorylation). The ap- 
pearance of protein M in fig.3b showed that it was 
feasible to label proteins by phosphate exchange 
and that dephosphorylation of protein M was fast 
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in the presence of elevated CAMP (i.e., half-time 
much less than 2 mm). 
Cyclic AMP-mediated decreases of phosphopro- 
tein labeling have been reported in several other 
systems [14-191, but this is the first report in which 
the mechanism For these decreases has been ex- 
plored. Our results show that carp-medjated 
decreases in phosphoprotein labeling result from 
net dephosphorylation of the proteins affected. 
For proteins d2, d4, and ds, we could not distin- 
guish whether CAMP-mediated effects were on a 
kinase or a phosphatase, but, for proteins dt and 
d3, rates of dephosphorylation were enhanced. The 
simplest explanation for this latter result is that 
CAMP-dependent phosphorylation stimulates the 
activity of a phosphoprotein phosphatase specific 
For proteins dr and d3, but we cannot exclude 
mechanisms by which CAMP indirectly activates a 
phosphatase. Whatever the mechanism, our results 
are the first to clearly implicate enhanced protein 
phosphatase activity among cellular responses to 
CAMP. 
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